Schedule Today
(800)-221-4291

Same Day Service

Drug, Alcohol and DNA Testing Centers, Abo, NM

Accredited Drug Testing, Inc. provides Drug, Alcohol and DNA Testing at testing centers in Abo, NM and the surrounding areas. To schedule a test call (800) 221-4291 or online 24/7. Testing is available for employers and individuals and most Abo, NM drug testing centers are within minutes of your home or office. Same day service is available and no appointment is needed in most cases.

Drug, Alcohol, DNA Testing Methods And Services

Drug and Alcohol Testing

Testing purposes can include pre-employment, random, post-accident, court ordered probation, school programs and personal reasons. DOT and non-DOT drug and alcohol testing is available. Testing centers offer 5, 7, 9, 12 and 14 panel drug screenings and all drug tests are analyzed by a SAMHSA Certified laboratory and all test results are verified by a licensed Medical Review Officer. Instant result testing is also available at most testing centers. Drug and Alcohol testing methods can include urine, hair, ETG, breath alcohol (BAC), blood and oral saliva. The detection period for drug and alcohol use is determined by the testing methods and the laboratory analysis utilized. Testing services are administered by trained and certified drug and alcohol testing technicians at all of our Abo, NM Drug Testing Centers.

Mobile/On-site Drug and Alcohol Testing

We come to you! In addition to our testing centers in Abo, NM and the surrounding areas, we also provide on-site drug and alcohol testing services utilizing our mobile/on-site unit for construction sites, hospitals, schools, roadside locations. When sending your employees to a drug testing center is not cost effective or a person cannot go to a testing center, our on-site mobile testing service may be a valuable option to consider. Please call us for additional information 800-221-4291.

DOT Testing and Services

Department of Transportation (DOT) drug and alcohol testing is provided at our Abo, NM testing centers for FMCSA, FAA, FRA, FTA, PHMSA, USCG and all Federally Regulated employers who have safety sensitive employees covered by DOT 49, CFR Part 40. Additional DOT services available include: Consortium membership (random testing pool), Supervisor Training, DOT Physicals and DOT drug policy development. Accredited Drug Testing can provide all services which will ensure compliance with the DOT Drug and Alcohol Testing Regulations.

DNA Testing

DNA testing is provided for various purposes including paternity, child custody, immigration and other legal proceedings. The DNA test is 99.9% accurate and is a simple swabbing of the mouth process. All DNA tests are analyzed by certified AABB laboratories and can be utilized in any legal proceeding.

Testing Centers located throughout New Mexico

In addition to our Drug, Alcohol and DNA testing centers located in Abo, NM and the surrounding areas, Accredited Drug Testing also has testing centers located in most cities throughout the State of New Mexico. Call us today to find the closest testing center near you.

Scheduling a Drug, Alcohol or DNA Test is fast and easy, call us today or click the express scheduling button.

800-221-4291

Schedule Drug, Alcohol, DNA Tests

(800) 221-4291

Schedule Your Test

"When You Need a Test, Choose the Best"

Accredited Drug Testing

Testing Centers Nationwide

(800)221-4291

For more information regarding the effects of drug abuse – Click Here

For more information on a drug free work place – Click Here

Local Area Info: ABO (gene)

Histo-blood group ABO system transferase is an enzyme with glycosyltransferase activity, which is encoded by the ABO gene in humans. It is ubiquitously expressed in many tissues and cell types. ABO determines the ABO blood group of an individual by modifying the oligosaccharides on cell surface glycoproteins. Variations in the sequence of the protein between individuals determine the type of modification and the blood group. The ABO gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.

The ABO gene resides on chromosome 9 at the band 9q34.2 and contains 7 exons. The ABO locus encodes three alleles. The A allele produces ?-1,3-N-acetylgalactosamine transferase (A-transferase), which catalyzes the transfer of GalNAc residues from the UDP-GalNAc donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into A antigen in A and AB individuals. The B allele encodes ?-1,3-galactosyl transferase (B-transferase), which catalyzes the transfer of Gal residues from the UDP-Gal donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into B antigen in B and AB individuals. Remarkably, the difference between the A and B glycosyltransferase enzymes is only four amino acids. The O allele lacks both enzymatic activities because of the frame shift caused by a deletion of guanine-258 in the gene which corresponds to a region near the N-terminus of the protein.This results in a frameshift and translation of an almost entirely different protein. This mutation results in a protein unable to modify oligosaccharides which end in fucose linked to galactose. Thus no A or B antigen is found in O individuals. This sugar combination is termed the H antigen. These antigens play an important role in the match of blood transfusion and organ transplantation. Other minor alleles have been found for this gene.

In human cells, the ABO alleles and their encoded glycosyltransferases have been described in several oncologic conditions. Using anti-GTA/GTB monoclonal antibodies, it was demonstrated that a loss of these enzymes was correlated to malignant bladder and oral epithelia. Furthermore, the expression of ABO blood group antigens in normal human tissues is dependent the type of differentiation of the epithelium. In most human carcinomas, including oral carcinoma, a significant event as part of the underlying mechanism is decreased expression of the A and B antigens. Several studies have observed that a relative down-regulation of GTA and GTB occurs in oral carcinomas in association with tumor development. More recently, a genome wide association study (GWAS) has identified variants in the ABO locus associated with susceptibility to pancreatic cancer.